sábado, 9 de abril de 2022

Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease - The Lancet Gastroenterology & Hepatology

Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease - The Lancet Gastroenterology & Hepatology

No hay comentarios:

Publicar un comentario